Fadogia Agrestis: What It Is and How It Works
Fadogia agrestis went from an obscure West African shrub to a trending testosterone booster almost overnight, largely thanks to podcasts. Our editorial team looked at where the claims come from, what the science really covers and why caution is warranted.
What Fadogia Agrestis Is
Fadogia agrestis is a shrub in the coffee family (Rubiaceae) native to parts of West and Central Africa, including Nigeria. In traditional medicine, preparations of its stem have been used as an aphrodisiac and for male sexual complaints.
The plant contains alkaloids, saponins, flavonoids and other phytochemicals. Which, if any, of these drive its reported effects has not been clearly identified, and commercial extracts are rarely standardized to a defined marker compound.
In the United States, Fadogia is sold as a dietary supplement. Under DSHEA, manufacturers do not have to prove safety or effectiveness before marketing, and the FDA has not evaluated these products. It is not specifically named on the WADA list, but testosterone-boosting supplements carry a known contamination risk.
Most US products are capsules containing a few hundred milligrams of stem extract, sometimes combined with tongkat ali, zinc or other ingredients marketed for male hormonal health.
Where the Testosterone Claims Come From
Virtually all the evidence comes from a series of rat studies by Yakubu, Akanji and Oladiji in Nigeria in the mid-2000s. In these experiments, an aqueous stem extract given to male rats increased serum testosterone and enhanced mating behavior compared with controls.
The researchers suggested the extract might stimulate testosterone production in Leydig cells, possibly by raising luteinizing hormone or acting more directly on the testes. These mechanisms were proposed, not proven.
Crucially, there are no published, peer-reviewed randomized controlled trials in humans examining Fadogia's effect on testosterone, muscle mass or performance. Everything consumers hear about human benefits is an extrapolation from rodents.
Safety Concerns: Testicular and Organ Toxicity
The same research group that reported increased testosterone also described worrying findings. In studies of longer administration, they noted changes in testicular tissue and biochemical markers that could indicate testicular toxicity.
Other measurements in rats suggested possible effects on liver and kidney function markers at higher doses. Animal findings do not translate directly to humans, but they are a red flag in the absence of human safety data.
Because of these signals, some promoters recommend cycling Fadogia, for example taking breaks every few weeks. There is no evidence that cycling prevents toxicity; it is simply a guess layered on top of rodent data.
Reviews of testosterone booster supplements, such as Clemesha and colleagues, have found that most marketed ingredients lack clinical support, and some formulations contain ingredients with possible harms. Fadogia fits this pattern.
Who Should Avoid It
- Men trying to conceive, given the testicular findings in animals
- Anyone with liver or kidney disease
- People with hormone-sensitive conditions, including prostate cancer
- Adolescents and young adults whose endocrine systems are still maturing
- Women, especially if pregnant or breastfeeding
- Tested athletes, because of contamination risk in booster products
Men taking prescribed testosterone or other hormone therapy should not add Fadogia, since the combined effects are unknown and could complicate monitoring.
Anyone experiencing testicular pain, changes in testicular size, unexplained fatigue or dark urine while using the supplement should stop and seek medical evaluation.
Laboratory values such as total testosterone, LH, liver enzymes and kidney markers can help a physician assess what is going on, but they should be interpreted in clinical context, not used to self-titrate a supplement.
Smarter Approaches to Healthy Testosterone
| Factor | Effect on testosterone | Strength of evidence |
|---|---|---|
| Adequate sleep (7–9 h) | Short sleep can lower levels | Good |
| Healthy body weight | Obesity associated with lower levels | Strong |
| Resistance training | Supports overall hormonal health | Moderate |
| Correcting zinc or vitamin D deficiency | May help if deficient | Moderate |
| Fadogia agrestis | Unknown in humans | Animal data only |
Lifestyle factors have far more robust evidence than any herbal booster. Losing excess weight, sleeping enough, limiting alcohol and training consistently are the foundations.
When true hypogonadism is suspected, the Endocrine Society recommends confirming low testosterone with repeated morning measurements and investigating the cause before considering treatment.
Treatment, if needed, should be prescribed and monitored by a physician, with attention to fertility, red blood cell counts and cardiovascular health.
Editorial Team Conclusions
Fadogia agrestis is a traditional African plant whose testosterone-boosting reputation rests almost entirely on rat experiments.
There are no solid human trials showing benefit, and animal studies raised concerns about testicular and organ toxicity.
Until better data exist, our editorial team considers Fadogia an unproven supplement with uncertain safety, especially for men who care about fertility.
For related reading, see our articles on tongkat ali myths, natural testosterone support through lifestyle and how to interpret a male hormone panel.
References
- Yakubu MT, Akanji MA, Oladiji AT. Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats. Asian J Androl. 2005;7(4):399–404.
- Yakubu MT, Akanji MA, Oladiji AT. Effects of oral administration of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem on some testicular function indices of male rats. J Ethnopharmacol. 2008;115(2):288–292.
- Clemesha CG, Thaker H, Samplaski MK. 'Testosterone boosting' supplements composition and claims are not supported by the academic literature. World J Mens Health. 2020;38(1):115–122.
- Balasubramanian A, Thirumavalavan N, Srivatsav A, et al. An analysis of popular online erectile dysfunction supplements. J Sex Med. 2019;16(6):843–852.
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744.
